Content
02/20/2024
Omaha, NE USA
University Medical Devices
completed $1.6 million Seed Round funding. Investors include
Bright Minds Capital Partners (lead), Invest Nebraska.
About
Revolutionizing the sampling experience for the diagnosis of respiratory illnesses, MicroWash is the first nasal specimen collection device that delivers a comfortable, fast and high-quality sample. Surpassing the nasal swab on virtually all levels ― including comfort, accuracy, stability and accessibility ― MicroWash sets the new gold standard for respiratory infection nasal sampling in a post-pandemic world, equally preferred by patients and medical professionals alike.
MicroWash is developed by University Medical Devices. Its mission is to provide cutting-edge and highly reliable specimen collection systems that improve the patient experience. The company’s leadership includes experts in neurology, emergency medicine, telehealth, urgent care, primary care, entrepreneurship and healthcare regulation with training at leading medical institutions.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
